Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil

G. Comella, R. Casaretti, P. Comella, A. Daponte, A. Parziale, V. Iervolino, G. Santillo, D. Zarrilli

Research output: Contribution to journalArticlepeer-review

Abstract

A new combination chemotherapy including mitoxantrone 10 mg/m2 i.v. on day 1 and 5-fluorouracil 400 mg/m2 i.v. plus folinic acid 200 mg/m2 i.v. on days 1-5 was administered every 28 days to 13 patients with locally advanced or metastatic cocon (1 case), rectosigmoid colon (4 cases), or rectum (8 cases) carcinoma. The median number of cycles performed was 3 (range, 1-9). No patient achieved complete or partial remission with this regimen, whereas 5 showed a stable disease lasting 3-8 months. Acute toxicity was mild/moderate in intensity and comparable to that reported with the standard 5-fluorouracil + folinic acid combination. Since we observed no major responses in our 13 consecutive patients, we consider that the overall activity of our regimen, at the doses and schedule utilized, was only moderately effective in advanced colorectal carcinoma.

Original languageEnglish
Pages (from-to)445-446
Number of pages2
JournalTumori
Volume77
Issue number5
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Treatment of advanced colorectal cancer with mitoxantrone, high dose folinic acid and fluorouracil'. Together they form a unique fingerprint.

Cite this